Innospan

Innospan is a medical innovation exchange system; and has been called ‘the NYSE for medical device innovations.’

Innospan operates an innovation exchange for medical device innovations. Participants use it for buying, selling, and seeing the overall, and acutely applicable developments, within medical device innovation. The system solicits and consolidates all of the medical device discoveries, patents, and innovations, from over 1 million physicians, as well as hospitals, universities, government, and even medical device firm’s interested in selling, outsourcing, or licensing their under-used IP portfolios. Innovations are categorized with contextual details based on relevant or related diagnoses, procedures, device categories, and usage by medical fields and subspecialties. Each innovation comes with an ‘Innospan score’—which reflects the overall viability and appeal of the innovation. This is based on factors such as development stage, real-world use cases, market, and many others. Each score is a composite of the individual assessments and feedback of vetting physicians, clinicians, IP attorneys, and medical device executives. The Innospan score directly equates to the proposed monthly licensing amount.

Innospan makes it easier for the inventors, the manufacturers, and every party in-between, to connect and correlate easier and faster than ever before.

Company’s Keywords:

medical device innovation development, innovation licensing, medical & biosciences innovation & invention development, ideation, development, production, licensing, acquisition, manufacturing